Bloomer Aaron (CIK 2019003) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-23). Recent activity: Sell EXAS (138,679 shares), Sell EXAS (417 shares), Buy EXAS (89,911 shares), Buy EXAS (38,715 shares), Sell EXAS (17,151 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-23 | EXACT SCIENCES CORP (EXAS) | EVP, Chief Financial Officer | Sell | 138,679 | $0 |
| 2026-03-23 | EXACT SCIENCES CORP (EXAS) | EVP, Chief Financial Officer | Sell | 417 | $0 |
| 2026-03-23 | EXACT SCIENCES CORP (EXAS) | EVP, Chief Financial Officer | Buy | 89,911 | $0 |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, Chief Financial Officer | Buy | 38,715 | $0 |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, Chief Financial Officer | Sell | 17,151 | $1.7M |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, Chief Financial Officer | Buy | 24,384 | $0 |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, Chief Financial Officer | Sell | 10,803 | $1.1M |
| 2025-04-17 | EXACT SCIENCES CORP (EXAS) | EVP, Chief Financial Officer | Sell | 5,120 | $226,560 |
| 2025-04-17 | EXACT SCIENCES CORP (EXAS) | EVP, Chief Financial Officer | Buy | 11,556 | $0 |
| 2025-04-17 | EXACT SCIENCES CORP (EXAS) | EVP, Chief Financial Officer | Buy | 12,904 | $0 |
| 2025-04-17 | EXACT SCIENCES CORP (EXAS) | EVP, Chief Financial Officer | Sell | 5,717 | $252,977 |
Source: SEC Form 4 filings · as of 2026-03-23